Abetalipoproteinemia, an inherited human disease characterized by a near-complete absence of the apolipoprotein (apo) B-containing lipoproteins in the plasma, is caused by mutations in the gene for microsomal triglyceride transfer protein (MTP). We used gene targeting to knock out the mouse MTP gene (Mttp). In heterozygous knockout mice (Mttp؉͞؊ ), the MTP mRNA, protein, and activity levels were reduced by 50%, in both liver and intestine. Compared with control mice (Mttp؉͞؉), chow-fed Mttp؉͞؊ mice had reduced plasma levels of low-density lipoprotein cholesterol and had a 28% reduction in plasma apoB100 levels. On a high-fat diet, the Mttp؉͞؊ mice exhibited a marked reduction in total plasma cholesterol levels, compared with those in Mttp؉͞؉ mice. Both the livers of adult Mttp؉͞؊ mice and the visceral endoderm of the yolk sacs from Mttp؉͞؊ embryos manifested an accumulation of cytosolic fat. All homozygous embryos (Mttp؊͞؊) died during embryonic development. In the visceral endoderm of Mttp؊͞؊ yolk sacs, lipoprotein synthesis was virtually absent, and there was a marked accumulation of cytosolic fat droplets. In summary, half-normal MTP levels do not support normal levels of lipoprotein synthesis and secretion, and a complete deficiency of MTP causes lethal developmental abnormalities, perhaps because of an impaired capacity of the yolk sac to export lipids to the developing embryo.
Abetalipoproteinemia is an inherited human disease characterized by extremely low plasma levels of cholesterol and triglycerides and a virtual absence of the apolipoprotein (apo) B-containing lipoproteins [chylomicrons, very-low-density lipoproteins (VLDL), and low-density lipoproteins (LDL)] in the plasma (1, 2) . Affected humans manifest intestinal fat malabsorption and frequently develop severe neurological problems as a result of deficient intestinal absorption of vitamin E, a fat-soluble vitamin (3) . Abetalipoproteinemia is caused by mutations in the gene for the 97-kDa catalytic subunit of microsomal triglyceride transfer protein (MTP) (4) (5) (6) . MTP is thought to transfer lipids to the apoB polypeptide chain as it is translated on the ribosome, allowing apoB to translocate into the lumen of the endoplasmic reticulum and assume the proper conformation for lipoprotein assembly (7, 8) . In abetalipoproteinemia, apoB is synthesized but cannot form lipoproteins and is degraded (9) .
Abetalipoproteinemia is considered to be an autosomal recessive syndrome, requiring two defective MTP alleles for disease expression. Parents of affected patients are said to have plasma lipid levels within the normal range (1) . The normal plasma lipid levels in obligate heterozygotes have given rise to the concept that MTP normally is present in great excess within lipoprotein-secreting cells. That is, if MTP normally were present within microsomes in great excess, then halfnormal MTP levels in obligate heterozygotes would not be expected to affect lipoprotein secretion rates or plasma lipid levels. Against this concept, however, are recent in vitro data on lipoprotein secretion from human hepatoma cells and rat hepatocytes cultured in the presence of MTP inhibitor drugs (refs. 10-13; J. Wetterau, personal communication) . These studies have shown that the extent of inhibition of lipoprotein secretion caused by MTP inhibitor drugs is roughly proportional to the extent of inhibition of MTP activity. In other words, inhibiting MTP activity levels by Ϸ50% results in an Ϸ50% reduction in lipoprotein secretion. These experiments with MTP inhibitor drugs obviously do not support the concept that MTP is present in great excess within cells and make it difficult to understand why obligate heterozygotes would have normal plasma lipid and lipoprotein levels. There are several potential explanations for this apparent paradox, one being that human ''abeta heterozygotes'' actually have normal or near-normal MTP levels as a result of a compensatory up-regulation in MTP expression from the normal allele or as a result of a reduction in MTP mRNA or protein turnover. Unfortunately, there are no data to resolve this enigma; no one has measured MTP mRNA, protein, or activity levels in livers or intestines from human heterozygotes. Nor have there been any measurements of lipoprotein secretion from the lipoprotein-secreting tissues of human heterozygotes. Because of logistic and ethical hurdles involved in obtaining intestinal and liver tissue from healthy human subjects, it seems quite unlikely that these issues will ever be satisfactorily addressed in humans.
To gain insights into the relationship between MTP levels and lipoprotein secretion in a mammalian model, we used gene targeting in mouse embryonic stem cells to generate a mouse model for abetalipoproteinemia. Another rationale for these experiments was to assess the importance of MTP in mouse embryonic development. Homozygous apoB-deficient mouse embryos manifest severe neurodevelopmental abnormalities (14) (15) (16) . It has been hypothesized that these neurodevelopmental abnormalities are a result of the absence of lipoprotein secretion by the yolk sac, causing an impaired delivery of lipid nutrients to the developing embryo (17) . If this hypothesis were correct, one would predict that MTP deficiency might also cause neurodevelopmental abnormalities. The MTP gene knockout mice described herein test that prediction.
MATERIALS AND METHODS
Generation of MTP Knockout Mice. A PCR from exon 1 of the human MTP gene (with oligonucleotides 5Ј-CTGTAGC-CCACCTGTGTTTAATC-3Ј and 5Ј-AACAGAGGCAGAG-TACGAGGAG-3Ј) was used to identify a strain 129 P1 clone (Genome Systems, St. Louis) spanning the 5Ј portion of the mouse MTP gene (Mttp). A sequence-replacement genetargeting vector was constructed from a 15-kb SacI fragment spanning exons 1-3 of the Mttp gene. The coding sequence of exon 1 was interrupted with a neo cassette; the long arm contained 6.5 kb of sequences 5Ј to exon 1, and the short arm contained 1.5 kb of intron 1 sequences (Fig. 1 A) . The vector was electroporated into RF8 embryonic stem cells (18) , and a targeted clone was used to generate heterozygous Mttpdeficient mice (19) . Nearly all experiments with heterozygous knockout mice were performed with genetically identical F1 mice bred from chimeras (20) . Mice were weaned at 21 days of age and fed either a chow diet containing 4.5% fat (Ralston Purina) or a high-fat, high-cholesterol diet (15) .
RNase Protection Assays. To measure mRNA levels from liver, intestine, or yolk sac, we used RNase protection assays (21) . A 395-bp Mttp riboprobe was generated from a plasmid containing a ClaI-PstI fragment from the mouse Mttp cDNA. A riboprobe for apoB was generated as described previously (22) . A mouse ␤-actin riboprobe spanning ␤-actin cDNA nucleotides 480-559 was used as a control.
MTP Activity Assays and MTP Western Blots. Microsomal proteins from liver and intestine were isolated and microsomal triglyceride transfer activity was measured as described previously (4, 23) . Western blots of microsomal proteins were performed with a rabbit antiserum against bovine MTP (24) and chemiluminescence detection reagents; the intensity of the 97-kDa MTP protein was quantified with a GS300 transmittance͞reflectance scanning densitometer (Hoefer).
Measurements of Lipid and ApoB100 Levels. Measurement of cholesterol and triglyceride levels were performed by using enzymatic assays (15) , and the distribution of lipids within the plasma lipoprotein fractions was determined by fast performance liquid chromatography (FPLC) (15) . Tissue lipids were extracted as described previously (25) . The concentration of mouse apoB100 in the plasma was measured with a mAb-based solid-phase sandwich radioimmunoassay by using two mouse apoB100-specific mAbs, LF3 and LF5 (26) .
Metabolic Labeling of Primary Hepatocytes. Primary mouse hepatocytes were prepared, and 6 ϫ 10 5 cells were plated onto collagen-coated 38-mm wells (26) . Two hours after hepatocytes were plated, 50 l of Pro-mix (530 MBq͞ml; Amersham) was added to each dish. After a 3-h incubation at 37°C, the medium and cells were collected. The amount of cellular protein in different wells varied by Ͻ2%. The amounts of apoB48 and apoB100 in the media were assessed by loading 40 l of the medium onto SDS-polyacrylamide gels. Dried gels were analyzed by autoradiography and a PhosphorImager (Fuji Bio-Imaging Analyzer, Fuji Medical Systems, Stamford, CT). The density distribution of the 35 S-labeled lipoproteins was analyzed by discontinuous sucrose gradient ultracentrifugation (26) .
Histology and Electron Microscopy of Tissues. Tissue from adult mice and embryos was examined by routine histologic studies. Electron microscopy of the visceral endoderm of the yolk sacs was performed as described previously (17) .
RESULTS
Mttp Knockout Mice. A 15-kb SacI fragment spanning exons 1-3 of the mouse Mttp gene was mapped and partially sequenced, revealing an exon͞intron structure identical to that of the human and hamster genes (6, 27) . A sequencereplacement vector was constructed (Fig. 1A ) and used to generate heterozygous MTP knockout mice (Mttpϩ͞Ϫ). Mttpϩ͞Ϫ mice, which were healthy and fertile, were intercrossed in an attempt to obtain homozygous Mttp knockout mice; however, no MttpϪ͞Ϫ mice were identified among 123 weaned offspring (Table 1) . To investigate this finding, embryos were genotyped at several time points during development ( Fig. 1B and Table 1 ). At embryonic day 9.5 (E9.5), MttpϪ͞Ϫ embryos were present at the expected Mendelian frequency, but they were retarded in their growth and had open anterior neuropors (Fig. 2B) . By E10.5, most of the MttpϪ͞Ϫ embryos appeared necrotic, and the anterior neuropor remained open (Fig. 2C) . At this stage, in situ hybridization studies revealed Mttp expression in the visceral endoderm of the yolk sac, but no signal was detectable within the embryo itself (data not shown). At E14.5, a large fraction of the embryos (32% of the total) was hemorrhagic and in an advanced stage of resorption, and the distribution of the surviving embryos was significantly different from a Mendelian ratio (P Ͻ 0.01 by 2 ). Only five viable MttpϪ͞Ϫ embryos were identified at E14.5, and each had exencephalus (Fig. 2D) . Thus, most MttpϪ͞Ϫ embryos die around E10.5, and the few that survive past this time point have severe neurodevelopmental abnormalities. Why the majority of MttpϪ͞Ϫ embryos die around E10.5 is not clear, but it may be relevant that the E9.5 embryos and their yolk sacs were pale. The blood islands in the yolk sac membranes of Mttpϩ͞ϩ and Mttpϩ͞Ϫ embryos were filled with hematopoietic cells on E10.5 (Fig. 2E) ; in contrast, these cells were rarely observed in the yolk sac blood islands of MttpϪ͞Ϫ embryos (Fig. 2F) . A blood smear from one of the surviving E14.5 MttpϪ͞Ϫ embryos revealed very few mature erythrocytes, compared with a blood smear from a Mttpϩ͞ϩ embryo (data not shown).
Disruption of a Single Mttp Allele Reduces MTTP mRNA Levels and Triglyceride Transfer Activity. As judged by an RNase protection assay, Mttp mRNA levels were highest in the intestine, with moderate levels in the liver and lower amounts in the yolk sac, kidney, and heart. As expected, the Mttp mRNA was undetectable in the yolk sacs of MttpϪ͞Ϫ mice (Fig. 3A) .
The mutant Mttp allele has been designated Mttp tm1Sgy . In this paper, we refer to it as MttpϪ. The Mttp mRNA in Mttpϩ͞Ϫ mice was reduced by one-half in the liver, intestine, and yolk sac (Table 2) ; thus, there was no evidence that the remaining wild-type allele was up-regulated to compensate for the disrupted Mttp allele. We found no evidence that MTP deficiency affected apoB mRNA levels; the apoB mRNA levels were identical in the liver and intestine of adult Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice, and in the yolk sacs from Mttpϩ͞ϩ, Mttpϩ͞Ϫ, and MttpϪ͞Ϫ mice ( Table 2) . To assess the possibility that Mttpϩ͞Ϫ mice might have normal MTP protein or activity levels despite half-normal mRNA levels (e.g., perhaps as a result of decreased turnover of the MTP protein), we compared MTP protein and activity levels in Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice. Microsomal triglyceride transfer activity in the Mttpϩ͞Ϫ livers and intestine was one-half of that observed with the Mttpϩ͞ϩ mice (Fig. 3B) . MTP protein levels in the liver, as assessed by densitometric analysis of Western blots of SDS-polyacrylamide gels, also were half-normal (45 Ϯ 12%; n ϭ 6), compared with liver samples from Mttpϩ͞ϩ mice (n ϭ 6).
Decreased Levels of Lipids and Apo-B100 in Mttp؉͞؊ Mice. There were no significant differences in the plasma concentrations of total cholesterol or triglycerides in Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice (Table 3) . However, as judged by FPLC fractionation studies, Mttpϩ͞Ϫ mice exhibited a small but consistent reduction in intermediate density lipoprotein (IDL)͞LDL cholesterol levels (a 28% and a 16% reduction in two independent experiments) (Fig. 4) . The reduced concentrations of IDL͞LDL cholesterol suggested that the Mttpϩ͞Ϫ mice might have reduced plasma levels of apoB100. To test that idea, we measured plasma apoB100 levels with a mAb-based radioimmunoassay. A highly significant Ϸ28% reduction in apoB100 levels was observed in chow-fed Mttpϩ͞Ϫ male and female mice, compared with sex-matched Mttpϩ͞ϩ littermate controls (Table 3) . Western blots of SDS-polyacrylamide gels (using a polyclonal mouse apoB-specific antiserum) revealed no difference in the ratio of apoB100 to apoB48 in the Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice (data not shown).
The livers of Mttpϩ͞Ϫ mice contained increased amounts of triglycerides (11.8 Ϯ 1.5 mg͞g vs. 9.6 Ϯ 1.0 mg͞g in Mttpϩ͞ϩ mice, n ϭ 5 in each group, P ϭ 0.04) and cholesterol (2.9 Ϯ 0.2 mg͞g vs. 2.4 Ϯ 0.4 mg͞g in Mttpϩ͞ϩ mice, P ϭ 0.07). Oil Red O-stained histological sections also revealed increased amounts of neutral lipids in livers of Mttpϩ͞Ϫ mice compared with Mttpϩ͞ϩ controls (data not shown). The reduction in IDL͞LDL cholesterol and apoB100 levels, along with increased liver triglyceride levels, indicated that half-normal levels of MTP activity are insufficient for normal levels of lipoprotein secretion from the liver. Oil Red O staining of intestines from Mttpϩ͞ϩ mice did not reveal any fatty pathology; it is possible that the absence of intestinal fat accumulation could relate to the high Mttp mRNA levels in that tissue. Normalized to Apob mRNA levels, the levels of the Mttp mRNA in the intestine are 5-fold higher than in liver or yolk sac (Table 2) .
On a high-fat diet, the total plasma cholesterol levels were Ϸ20% lower in Mttpϩ͞Ϫ mice (Table 3) than Mttpϩ͞ϩ mice (P ϭ 0.007), as a result of a marked decrease in the amount of VLDL and LDL cholesterol (Fig. 4) . ApoB100 plasma levels tended to be lower in the Mttpϩ͞Ϫ mice than in Mttpϩ͞ϩ mice in two separate experiments, but this difference did not achieve statistical significance (Table 3) . However, when a series of dilutions of pooled plasma samples from 6-10 Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice on a high-fat diet were compared in a radioimmunoassay, we invariably observed a 15-20% reduction in apoB100 levels in the Mttpϩ͞Ϫ mice (data not shown).
To confirm that the low plasma apoB100 concentrations in Mttpϩ͞Ϫ mice were caused by a decrease in apoB secretion from cells, we assessed apoB accumulation in the medium of primary hepatocytes prepared from chow-fed Mttpϩ͞ϩ and Mttpϩ͞Ϫ mice. There was invariably less apoB48 and apoB100 accumulation in the medium of Mttpϩ͞Ϫ hepatocytes, compared with Mttpϩ͞ϩ primary hepatocytes (Fig. 5A) . Triglyceride transfer activity levels were half-normal in cultured Mttpϩ͞Ϫ hepatocytes (Fig. 5B) ; Mttpϩ͞Ϫ cells had halfnormal levels of Mttp mRNA (55 Ϯ 8% of Mttpϩ͞ϩ hepatocytes) and normal levels of apoB mRNA (106 Ϯ 8% of Mttpϩ͞ϩ hepatocytes). As judged by PhosphorImager analy- Genotypes were determined by Southern blot analysis as described in the legend to Fig. 1 . NA, not applicable. *Most of these embryos appeared to be necrotic. † All five embryos had exencephalus. (1998) sis, there was 19 Ϯ 5% (mean Ϯ SD) less apoB100 and 22 Ϯ 5% less apoB48 in the medium from Mttpϩ͞Ϫ cells (P ϭ 0.05) (Fig. 5) . Sucrose density gradient ultracentrifugation of the 35 S-labeled lipoproteins revealed no differences in the density profiles of the lipoproteins secreted by Mttpϩ͞ϩ and Mttpϩ͞Ϫ cells (data not shown).
FIG. 2. Phenotype of MttpϪ͞Ϫ embryos. (A)
Reduced Mttp Gene Expression Is Associated with Lipid Accumulation in the Visceral Endoderm of the Yolk Sac. Hematoxylin and eosin-stained sections of the yolk sacs of MttpϪ͞Ϫ embryos revealed vacuolization of the basolateral surface of the yolk sacs (Fig. 2F) . Staining of frozen sections with Oil Red O indicated that these vacuoles were cytosolic lipid droplets (Fig. 6A) . In contrast, only trace amounts of Oil Red O staining were observed in Mttpϩ͞ϩ yolk sacs. The yolk sac membranes of Mttpϩ͞Ϫ embryos had an intermediate level of fat accumulation, indicating that half-normal levels of MTP activity were insufficient to prevent fat accumulation in that tissue.
Examination of imidazole-stained yolk sacs by electron microscopy confirmed the presence of massive amounts of cytosolic lipid droplets at the basolateral surfaces of the visceral endoderm of MttpϪ͞Ϫ yolk sacs (not shown). Moreover, these studies revealed that defective lipoprotein assembly is the likely cause of this finding. In yolk sacs from E9.5 Mttpϩ͞ϩ and Mttpϩ͞Ϫ embryos, there were numerous VLDL-sized lipoproteins within the endoplasmic reticulum and Golgi apparatus (Fig. 6B) . In contrast, lipoprotein production was almost always absent in the visceral endoderm cells from E9.5 MttpϪ͞Ϫ embryos (Fig. 6C ). Only very rare lipid-staining particles were observed in the MttpϪ͞Ϫ cells.
DISCUSSION
In this study, we demonstrate that half-normal levels of the MTP mRNA, protein, and triglyceride transfer activity in tissues of Mttpϩ͞Ϫ mice are insufficient for normal levels of lipoprotein secretion. The hepatocytes of the Mttpϩ͞Ϫ mice had reduced MTP levels and they exhibited fewer apoBcontaining lipoproteins in the incubation medium, compared with hepatocytes from wild-type mice. On a chow diet, plasma levels of IDL͞LDL cholesterol and apoB100 were reduced significantly in Mttpϩ͞Ϫ mice, and on a high-fat diet, total cholesterol as well as VLDL and LDL cholesterol levels were reduced markedly. The lower plasma lipoprotein levels and the reduction in lipoprotein secretion from hepatocytes were accompanied by increased amounts of triglycerides within the liver and visceral yolk sac endoderm of Mttpϩ͞Ϫ mice. These data indicate that there is no physiological compensation for reduced levels of MTP gene expression in Mttpϩ͞Ϫ mice and that half-normal levels of MTP gene expression are accompanied by an unequivocal phenotype: decreased secretion of apoB and reduced plasma apoB levels. Thus, at least in the mouse, abetalipoproteinemia is a codominant rather than a recessive syndrome and, in this respect, is similar to familial hypobetalipoproteinemia, a codominant syndrome caused by apoB gene defects (14, 15, 28) .
Textbooks (1) and reviews (7) have invariably stated that abetalipoproteinemia in humans is a classic recessive syndrome, with parents having normal plasma lipid levels. Indeed, several parents of abetalipoproteinemia patients have been reported to have total plasma cholesterol levels greater than 250 mg͞dl (2, 29, 30) , so at least some human ''abeta heterozygotes'' may be truly unaffected by half-normal MTP levels. On the other hand, it seems possible that heterozygosity for MTP deficiency could reduce LDL cholesterol and apoB levels by an average of Ϸ20%-similar to what we observed in mice-and that this effect might be overlooked within the extremely broad range of ''normal'' cholesterol levels. It is noteworthy that several cases of abetalipoproteinemia have Mttp and Apob mRNA levels were determined by RNase protection assays and were normalized to the signal for ␤-actin mRNA. Values are reported as means Ϯ SD. NA, not applicable. The plasma lipoproteins were size-fractionated on an FPLC column, and the cholesterol concentration in each fraction was measured enzymatically (15) . (Left) Distribution of cholesterol in the plasma of mice fed a chow diet. The study was performed with plasma pooled from three female mice in each group. The FPLC profiles did not suggest that the size of Mttpϩ͞ϩ and Mttpϩ͞Ϫ lipoproteins differed. This conclusion was supported by electron microscopy, which showed the VLDL size distribution to be identical in chow-fed Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice. (Right) Distribution of plasma cholesterol after 5 weeks on a high-fat diet. The study was performed with plasma pooled from four male mice in each group. Once again, electron microscopy revealed no differences in the VLDL size distribution in Mttpϩ͞Ϫ and Mttpϩ͞ϩ mice.
been described in which the parents had fairly low plasma lipid levels. Prior to the era of molecular genetics, Salt et al. (31) reported a case of ''a-␤-lipoproteinemia'' (the first case given this designation) in which both parents had very low total plasma cholesterol levels (127 and 107 mg͞dl). Although it might be argued that both parents actually may have had an APOB null allele, our results in Mttpϩ͞Ϫ mice make it plausible that the parents of Salt's patient might have had hypocholesterolemia on the basis of reduced MTP activity levels. In the era of molecular genetics, there have been only a handful of genotypically proven human ''MTP heterozygotes'' for which lipid and apoB levels have been reported (29) . From 15 heterozygotes, 7 had fairly low total cholesterol levels (133, 137, 148, 151, 161, 164, and 164 mg͞dl), and 6 had distinctly low apoB levels (15, 28, 25, 38, 42 , and 45 mg͞dl) (29) . These observations suggest that heterozygous MTP deficiency might result in hypocholesterolemia, at least in some humans. However, defining the effect of heterozygous MTP deficiency in humans in a definitive fashion obviously would require analyzing many large human kindreds with large numbers of genotypically proven heterozygotes.
The current studies provide new information regarding apoB mRNA levels in the setting of MTP deficiency. APOB mRNA levels have been reported to be significantly elevated in human patients with abetalipoproteinemia (32-34), suggesting the possibility of a feedback up-regulation of apoB gene transcription in the setting of deficient lipoprotein assembly. Using controlled RNase protection assays, we found Apob mRNA levels to be identical in Mttpϩ͞ϩ and Mttpϩ͞Ϫ adult mice and in Mttpϩ͞ϩ, Mttpϩ͞Ϫ, and MttpϪ͞Ϫ yolk sacs. Our results are consistent with prior studies showing very small or absent changes in hepatic apoB mRNA levels in response to profound dietary interventions (35, 36) or genetic interventions that cause massive fat accumulation in the liver (37); however, we recognize that studies with livers from adult mice with complete MTP deficiency (i.e., liver-specific knockout mice) would be helpful in further analyzing this issue.
Most of the homozygous Mttp knockout embryos died at midgestation, and the few that survived past that time point had exencephalus, a phenotype first observed by Homanics et al. (14) in the setting of apoB70 mice and later by others in the setting of Apob gene knockouts (15, 16) . At the light and electron microscopy level, there was a substantial accumulation of cytosolic fat in the MttpϪ͞Ϫ visceral yolk sac endoderm, ref lecting deficient lipoprotein secretionvirtually identical to pathology observed in ApobϪ͞Ϫ yolk sacs (17) . In their analysis of ApobϪ͞Ϫ embryos, Farese et al. (17) suggested that deficient yolk sac lipoprotein production might reduce the delivery of lipid nutrients to the developing embryo at a critical time point when the chorioallantoic placenta is not yet established. In this study, we noted that the MttpϪ͞Ϫ embryos were pale and appeared to be deficient in erythropoiesis. Defects in erythropoiesis are known to be a cause of midgestational embryonic death (38) . We speculate that impaired lipid nutrition might interfere with the capacity of the embryo to generate new red blood cells. The cause of the neurodevelopmental abnormalities has not been defined precisely, but we speculate that this finding could be a result of either deficient delivery of lipids for cell membranes in the brain or, more simply, a deficiency of fuel for developing neurons. (B) Triglyceride transfer activity and quantification of total apoB secretion in Mttpϩ͞ϩ and Mttpϩ͞Ϫ primary hepatocytes. Triglyceride transfer assays were performed as described (4, 23) ; the amounts of 35 S-labeled apoB48 and apoB100 in the media were quantified with a PhosphorImager and normalized to the amount of a non-apoB protein in the media (''control band''). The amount of total apoB (apoB100 and apoB48) in the medium was 21 Ϯ 5% less in Mttpϩ͞Ϫ primary hepatocytes, compared with Mttpϩ͞ϩ cells (P ϭ 0.05 by t test, n ϭ 4 mice). This experiment was repeated twice, with the same results. At the ultrastructural level, there were subtle differences in the yolk sacs of MttpϪ͞Ϫ embryos, compared with ApobϪ͞Ϫ yolk sacs (17) . In the ApobϪ͞Ϫ yolk sacs, apoB synthesis and secretion appeared to be completely absent, whereas very rare lipid-staining particles were observed within the Golgi compartments of the MttpϪ͞Ϫ yolk sacs. These results suggest the possibility that lipoprotein assembly could occur in the absence of MTP, but at an extremely low efficiency. This finding would be consistent with reports of trace levels of apoB-containing lipoproteins in the plasma of patients with abetalipoproteinemia (34, (39) (40) (41) .
